|
11
|
|
Tumor-on-chip as a personalized platform for rapid drug testing in breast cancer.
(linkinghub.elsevier.com)
|
Helal C
…
Descroix S
Cell Reports Medicine
2026-08-28
|
#organoid
#oncology
#drug sensitivity
#precision medicine
#microfluidics
|
|
7
|
|
Progress and challenges in expanding access to clinical trials in pancreatic cancer.
(nature.com)
|
Thang SS
…
Poh AR
Communications Medicine
2026-08-29
|
#clinical-trials
#pancreatic cancer
#oncology
#molecular testing
#healthcare_access
|
|
7
|
|
Identification of differential topologically associating domains from low sequencing depth and pseudo-bulk chromatin contact maps.
(genome.cshlp.org)
|
Li J
…
Gao L
Genome Research
2026-08-28
|
#chromatin
#sequencing
#machine learning
#3d genome
#oncology
|
|
3
|
|
Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial.
(linkinghub.elsevier.com)
|
Sun HC
…
Fan J
The Lancet
2026-08-22
|
#hepatocellular carcinoma
#immunotherapy
#surgery
#clinical trial
#oncology
|
|
2
|
|
Rewiring immunity with in vivo CAR T cell engineering.
(nature.com)
|
Slaney CY
…
Darcy PK
Nature Cancer
2026-08-21
|
#immunotherapy
#car-t
#oncology
#engineering
#lymphocyte
|
|
1
|
|
Scalable generation of hematopoietic stem cell-engineered off-the-shelf mono-specific cytotoxic T cells targeting solid tumors.
(linkinghub.elsevier.com)
|
Zhu Y
…
Yang L
Cell Reports Medicine
2026-08-19
|
#immunotherapy
#oncology
#cell engineering
#cytotoxicity
#manufacturing
|
|
1
|
|
Oncogenic USP3 promotes hepatocellular carcinoma progression via K11/K48-specific deubiquitination and stabilization of YAP.
(linkinghub.elsevier.com)
|
Peng Y
…
Zhou Y
iScience
2026-08-22
|
#hepatocellular carcinoma
#deubiquitination
#oncology
#protein-stabilization
#signaling
|
|
1
|
|
Neutrophil-integrated syncytial CAR macrophage for cancer immunotherapy.
(nature.com)
|
Tian T
…
Zhang Z
Nature Immunology
2026-08-18
|
#immunotherapy
#car-t
#macrophage
#oncology
#neutrophil
|
|
1
|
|
The role of FGFR signaling in SCLC and NSCLC: Current insights and therapeutic perspectives.
(linkinghub.elsevier.com)
|
Kim BC
…
Kim KB
iScience
2026-08-21
|
#lung cancer
#fgfr-signaling
#targeted therapy
#drug resistance
#oncology
|
|
1
|
|
STRA6-mediated ferroptosis and its potential association with antioxidant stress pathways in glioblastoma.
(linkinghub.elsevier.com)
|
Yang T
…
Zhang L
iScience
2026-08-21
|
#ferroptosis
#glioblastoma
#antioxidant
#oncology
#apoptosis
|
|
1
|
|
SeqUIaSCOPE: multi-omics data integration platform for Single-patient Clinical Oncology Pathway Exploration.
(academic.oup.com)
|
Juraskova K
…
Bystry V
Bioinformatics
2026-08-20
|
#oncology
#multi-omics
#genomics
#diagnostics
#pathway
|
|
0
|
|
Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.
(linkinghub.elsevier.com)
|
Motzer RJ
…
Schmidinger M
The Lancet
2026-08-12
|
#renal cell carcinoma
#immunotherapy
#clinical trial
#tyrosine-kinase-inhibitors
#oncology
|
|
0
|
|
Consensus on standardized later-line systemic therapy for hepatocellular carcinoma.
(linkinghub.elsevier.com)
|
Yu H
…
Lu Y
Drug Resistance Updates
2026-08-12
|
#hepatocellular carcinoma
#immunotherapy
#targeted therapy
#treatment-resistance
#oncology
|
|
0
|
|
Bronsted-basic small molecules activate GTP hydrolysis in KRAS-Q61 mutants.
(nature.com)
|
Wang YC
…
Zhang Z
Nature Chemical Biology
2026-08-12
|
#oncology
#kras
#inhibitor
#gtpase
#drug discovery
|
|
0
|
|
Intracranial delivery of B7-H3-targeting CAR-T cells for recurrent glioblastoma: a phase 1 trial.
(nature.com)
|
Zhang Y
…
Huang G
Nature Medicine
2026-08-06
|
#immunotherapy
#glioblastoma
#car-t
#clinical trial
#oncology
|
|
0
|
|
Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial.
(jamanetwork.com)
|
Zhou T
…
Zhang L
JAMA
2026-08-10
|
#nsclc
#egfr
#chemotherapy
#oncology
#immunotherapy
|
|
0
|
|
The next generation of antibody-drug conjugates.
(nature.com)
|
Mosele F
…
Andre F
Nature Medicine
2026-08-03
|
#immunotherapy
#oncology
#drug delivery
#antibody
#personalized medicine
|
|
0
|
|
Iparomlimab and tuvonralimab in previously treated patients with cervical cancer.
(linkinghub.elsevier.com)
|
Lou H
…
Liu J
Cell Reports Medicine
2026-08-04
|
#immunotherapy
#cervical cancer
#clinical trial
#checkpoint-inhibitors
#oncology
|
|
0
|
|
Leave No Data Behind: Exploring a new paradigm in oncology with foundation models and large language models.
(linkinghub.elsevier.com)
|
Corso F
…
Prelaj A
Cell Reports Medicine
2026-08-04
|
#oncology
#biomarker
#machine learning
#personalization
#diagnosis
|
|
0
|
|
LINGO1-targeted antibody-drug conjugates improve efficacy and tolerability of antineoplastic therapies in Ewing sarcoma models.
(jci.org)
|
Zhu Z
…
Liu P
Journal of Clinical Investigation
2026-08-03
|
#sarcoma
#oncology
#immunotherapy
|